非A非B型主动脉夹层:系统综述与荟萃分析
该系统综述与荟萃分析基于14项研究共433例非A非B型主动脉夹层患者,评估其自然病史与治疗结局。药物治疗患者30天死亡率为14%(7/50),而接受干预者30天死亡率为3.6%(95%CI 1.7-5.6%),逆行A型夹层为2.6%(95%CI 0.8-4.4%),卒中为2.8%(95%CI 1.0-4.5%)。作者提示早期干预可能有益,但需大样本前瞻性研究证实。
要点
- 非A非B型主动脉夹层药物治疗患者30天死亡率为14%(7/50)。
- 接受干预患者30天死亡率3.6%(95%CI 1.7-5.6%)。
- 干预后逆行A型夹层2.6%、卒中2.8%,提示早期干预可能获益。
核心结论
- 非A非B型主动脉夹层常需干预,药物治疗30天死亡率似乎高于手术或腔内治疗。
- 早期干预可能适用于非A非B型主动脉夹层,但需进一步大样本前瞻性研究证实。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE数据库,最终纳入14项研究共433例患者进行定量分析。
主要发现
- 药物治疗患者比例为5%至54%,合并率为36%(50/138)。
- 药物治疗患者30天死亡率为14%(7/50)。
- 接受干预患者30天死亡率3.6%(95%CI 1.7-5.6%),逆行A型夹层2.6%(95%CI 0.8-4.4%),卒中2.8%(95%CI 1.0-4.5%)。
临床怎么用
- 对于非A非B型主动脉夹层,应认识到其常需干预且药物治疗死亡率较高,可考虑早期干预。
局限性
- 存在报告偏倚和选择偏倚的可能性。
- 需要进一步大样本前瞻性研究确认早期干预的指征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Non-A non-B aortic dissections are rare, and little is known about their natural history, indications for surgery and operative results. We aim to examine the literature to summarize what is known of the natural history of non-A non-B dissections and evaluate the outcomes of the therapeutic options available. METHODS: An extensive literature search was performed using MEDLINE to find all published studies that report data on the natural history and outcomes of patients with non-A non-B aortic dissection. Data on patients treated with medical therapy were extracted to characterize the natural history. Primary end points included 30-day mortality, stroke and retrograde type A dissection. RESULTS: Of the 423 studies found, 14 articles (433 patients) fulfilled the inclusion criteria for quantitative analysis. The proportion of medically treated patients ranged from 5 to 54% with a pooled rate of 36% (50/138). The 30-day mortality of patients treated with medical therapy was 14% (7/50). The overall estimated proportion of 30-day mortality for patients who underwent intervention was 3.6% [95% confidence interval (CI) 1.7-5.6%], retrograde type A dissection was 2.6% (95% CI 0.8-4.4%) and stroke was 2.8% (95% CI 1.0-4.5%). CONCLUSIONS: Despite the likelihood of reporting and selection bias, patients with non-A non-B dissection often have a complicated course requiring some form of intervention. The 30-day mortality of patients treated with medical therapy seems higher than surgical or endovascular therapy. Ideally, further large prospective studies are necessary to confirm our suggestion that early intervention may be indicated in non-A non-B dissections.
引用
- Carino D, Singh M, Molardi A, et al. Non-A non-B aortic dissection: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2019. PMID: 30325419. doi:10.1093/ejcts/ezy337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。